Go Pro
→ PH: Do THESE 4 things to your bank account now … (From Weiss Ratings) (Ad)tc pixel Free IKT Stock Alerts

Inhibikase Therapeutics (IKT) Institutional Ownership

Inhibikase Therapeutics logo
$2.04 0.00 (0.00%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$1.99 -0.05 (-2.60%)
As of 07/10/2026 04:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Inhibikase Therapeutics (NASDAQ:IKT)

Current
Institutional Ownership
Percentage
3.81%
Number of
Institutional Buyers
(last 12 months)
40
Total
Institutional Inflows
(last 12 months)
$67.95M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$8.64M
Get IKT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inhibikase Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

IKT Institutional Buying and Selling by Quarter

Inhibikase Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/4/2026Seven Fleet Capital Management LP325,600$547K0.2%-39.0%0.247%
5/29/2026Perceptive Advisors LLC2,315,000$3.89M0.1%-57.3%1.753%
5/19/2026Bank of America Corp DE322,704$542K0.0%+595.3%0.244%
5/19/2026Ally Bridge Group NY LLC1,325,000$2.23M1.8%N/A1.004%
5/18/2026ADAR1 Capital Management LLC6,606,572$11.10M0.7%-18.1%5.004%
5/16/2026The Manufacturers Life Insurance Company 28,773$48K0.0%N/A0.022%
5/16/2026SummitTX Capital L.P.1,524,536$2.56M0.1%N/A1.155%
5/16/2026Kalehua Capital Management LLC3,821,890$6.42M4.6%+118.4%2.895%
5/15/2026Rangeley Capital LLC220,000$370K0.3%N/A0.167%
5/14/2026Renaissance Technologies LLC16,500$28K0.0%N/A0.012%
5/14/2026Sei Investments Co.47,962$81K0.0%N/A0.036%
5/5/2026Bank of New York Mellon Corp213,208$358K0.0%+55.1%0.161%
4/16/2026SG Americas Securities LLC15,480$26K0.0%N/A0.012%
2/26/2026Seven Fleet Capital Management LP533,648$1.09M0.8%N/A0.710%
2/23/2026Virtu Financial LLC22,869$47K0.0%+70.1%0.030%
2/18/2026ADAR1 Capital Management LLC8,063,949$16.53M1.2%+53.7%10.727%
2/18/2026XTX Topco Ltd20,298$42K0.0%N/A0.027%
2/18/2026Squadron Capital Management LLC4,225,000$8.66M3.7%N/A5.620%
2/18/2026Millennium Management LLC169,850$348K0.0%N/A0.226%
2/17/2026ADAR1 Capital Management LLC8,063,949$16.53M1.2%+53.7%10.727%
2/17/2026Integral Health Asset Management LLC1,750,000$3.59M0.2%N/A2.328%
2/17/2026Persistent Asset Partners Ltd93,430$192K0.1%N/A0.124%
2/16/2026Spruce Street Capital LP3,581,603$7.34M2.4%N/A4.764%
2/16/2026Sands Capital Alternatives LLC13,018,965$26.69M5.1%+18.9%17.318%
2/16/2026Barclays PLC94,795$194K0.0%+10.8%0.126%
2/13/2026Nantahala Capital Management LLC3,929,292$8.06M0.3%+79.4%5.227%
2/13/2026Kalehua Capital Management LLC1,750,000$3.59M3.3%N/A2.328%
2/13/2026Exome Asset Management LLC600,000$1.23M0.6%N/A0.798%
2/13/2026Siren L.L.C.5,850,000$11.99M0.4%N/A7.782%
2/13/2026State Street Corp554,849$1.14M0.0%+9.3%0.738%
2/13/2026Wells Fargo & Company MN67,833$139K0.0%+48.3%0.090%
2/12/2026Jane Street Group LLC116,003$238K0.0%N/A0.154%
2/11/2026Deutsche Bank AG54,909$113K0.0%-31.8%0.073%
2/10/2026Goldman Sachs Group Inc.85,267$175K0.0%+694.3%0.113%
2/9/2026Geode Capital Management LLC1,128,239$2.31M0.0%+1.4%1.501%
1/29/2026Sanctuary Advisors LLC12,539$26K0.0%N/A0.017%
1/1/2026JPMorgan Chase & Co.49,937$81K0.0%+74.7%0.066%
11/17/2025Susquehanna International Group LLP45,605$74K0.0%-88.1%0.061%
11/17/2025Citadel Advisors LLC71,670$116K0.0%N/A0.096%
11/14/2025ADAR1 Capital Management LLC5,247,603$8.50M0.8%+2.5%7.042%
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
11/13/2025BNP Paribas Financial Markets15,640$25K0.0%+70.3%0.021%
11/7/2025Vanguard Group Inc.3,273,339$5.30M0.0%+1.5%4.393%
11/7/2025JPMorgan Chase & Co.49,937$81K0.0%+74.7%0.067%
11/3/2025New York State Common Retirement Fund47,900$78K0.0%-21.1%0.064%
8/15/2025Perceptive Advisors LLC5,432,293$10.59M0.9%-8.3%7.307%
8/15/2025Bank of America Corp DE19,216$37K0.0%-57.3%0.026%
8/14/2025Commodore Capital LP5,397,488$10.53M0.7%+1.0%7.260%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.33,023$64K0.0%N/A0.044%
8/13/2025Stonepine Capital Management LLC733,793$1.43M1.4%-19.8%0.987%
8/13/2025Invesco Ltd.30,712$60K0.0%N/A0.041%
8/13/2025New York State Common Retirement Fund60,700$118K0.0%N/A0.082%
8/12/2025JPMorgan Chase & Co.28,579$56K0.0%N/A0.038%
8/8/2025Intech Investment Management LLC31,406$61K0.0%N/A0.042%
8/8/2025Police & Firemen s Retirement System of New Jersey17,638$34K0.0%N/A0.024%
8/8/2025Geode Capital Management LLC1,066,700$2.08M0.0%+228.5%1.435%
6/27/2025Goldman Sachs Group Inc.166,025$364K0.0%+277.7%0.223%
5/19/2025Jane Street Group LLC116,249$255K0.0%N/A0.156%
5/16/2025Goldman Sachs Group Inc.166,025$364K0.0%+277.7%0.223%
5/16/2025ADAR1 Capital Management LLC5,122,105$11.22M2.1%+0.4%6.890%
5/14/2025Stonepine Capital Management LLC914,973$2.00M1.9%-19.2%1.231%
5/9/2025Blair William & Co. IL155,953$342K0.0%+15.6%0.210%
5/6/2025Y Intercept Hong Kong Ltd26,775$59K0.0%N/A0.036%
2/27/2025Jefferies Financial Group Inc.14,800$48K0.0%N/A0.021%
2/18/2025Alpine Global Management LLC14,842$48K0.0%N/A0.021%
2/17/2025Soleus Capital Management L.P.6,325,000$20.56M1.3%N/A9.119%
2/17/2025Squarepoint Ops LLC28,411$92K0.0%N/A0.041%
2/17/2025Stonepine Capital Management LLC1,132,388$3.68M3.0%N/A1.633%
2/17/2025OMERS ADMINISTRATION Corp54,600$177K0.0%N/A0.079%
2/17/2025Millennium Management LLC142,209$462K0.0%N/A0.205%
2/17/2025Jefferies Financial Group Inc.14,800$48K0.0%N/A0.021%
2/17/2025Fairmount Funds Management LLC6,125,000$19.91M2.0%N/A8.831%
2/17/2025Blackstone Inc.2,070,684$6.73M0.0%N/A2.985%
2/17/2025Caxton Corp16,393$53K0.3%N/A0.024%
2/14/2025Nantahala Capital Management LLC2,190,000$7.12M0.3%N/A3.157%
2/14/2025Northern Trust Corp64,011$208K0.0%N/A0.092%
2/14/2025Alpine Global Management LLC14,842$48K0.0%N/A0.021%
2/14/2025Stifel Financial Corp13,129$43K0.0%N/A0.019%
2/13/2025Barclays PLC84,000$273K0.0%N/A0.121%
2/13/2025ADAR1 Capital Management LLC5,103,005$16.59M3.3%N/A7.357%
2/12/2025Geode Capital Management LLC322,878$1.05M0.0%+544.9%0.466%
2/12/2025Blair William & Co. IL134,953$439K0.0%+7.0%0.195%
8/15/2024Armistice Capital LLC589,575$713K0.0%N/A8.170%
11/15/2023Armistice Capital LLC186,046$259K0.0%-62.5%3.477%
9/21/2023Barclays PLC11,455$41K0.0%N/A0.214%
8/8/2023Hamilton Lane Advisors LLC13,802$50K0.0%-83.3%0.266%
5/2/2023Hamilton Lane Advisors LLC82,817$54K0.0%N/A0.286%
2/10/2023Blair William & Co. IL229,000$114K0.0%+27.9%0.817%
7/12/2022Koshinski Asset Management Inc.65,377$49K0.0%N/A0.259%
5/6/2022Retirement Planning Co of New England Inc.116,402$172K0.1%-21.0%0.461%
5/5/2022Lynwood Capital Management Inc.120,000$178K0.2%-52.9%0.476%
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
5/4/2022Hamilton Lane Advisors LLC165,635$245K0.1%N/A0.657%
5/3/2022Redmond Asset Management LLC122,682$182K0.1%N/A0.486%


IKT Institutional Ownership - Frequently Asked Questions

During the previous two years, 57 institutional investors and hedge funds held shares of Inhibikase Therapeutics. The most heavily invested institutionals were Sands Capital Alternatives LLC ($26.69M), Soleus Capital Management L.P. ($20.56M), Fairmount Funds Management LLC ($19.91M), Siren L.L.C. ($11.99M), ADAR1 Capital Management LLC ($11.10M), Commodore Capital LP ($10.53M), and Squadron Capital Management LLC ($8.66M).Learn more on Inhibikase Therapeutics' institutional investors.

3.81% of Inhibikase Therapeutics' stock is owned by institutional investors. Learn more on IKT's institutional investor holdings.

Of the 54 institutional investors that purchased Inhibikase Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: ADAR1 Capital Management LLC ($10.88M), Soleus Capital Management L.P. ($6.33M), Fairmount Funds Management LLC ($6.13M), Siren L.L.C. ($5.85M), Squadron Capital Management LLC ($4.23M), Nantahala Capital Management LLC ($3.93M), and Kalehua Capital Management LLC ($3.82M).

Institutional investors have bought a total of 35,215,867 shares in the last 24 months. This purchase volume represents approximately $67.95M in transactions.

The following institutional investors have sold Inhibikase Therapeutics stock in the last 24 months: Perceptive Advisors LLC ($3.60M), ADAR1 Capital Management LLC ($1.46M), Susquehanna International Group LLP ($337.47K), Seven Fleet Capital Management LP ($208.05K), Stonepine Capital Management LLC ($181.18K), Bank of America Corp DE ($25.81K), and Deutsche Bank AG ($25.59K).

Institutional investors have sold a total of 5,847,543 shares in the last 24 months. This volume of shares sold represents approximately $8.64M in transactions.


Related Companies

This page (NASDAQ:IKT) was last updated on 7/11/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel